Articles by Piyush Agarwal, MD
The panel conclude with their thoughts on considerations for TURBT and intravesical therapy versus chemoablation.
The panel considers therapies across different risk stratifications, including ATLAS, ENVISION, and BOND-003 studies.
The panel delves into treatment pathways, including considerations for ablation and repeated histologic evaluation.
The panel kicked off with conversations about risk stratification and classification of low-grade, intermediate-risk disease.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.